Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical firm dedicated to developing novel prescription drugs for the treatment of severe pain in the United States, with a specific focus on preventing opioid addiction, misuse, abuse, and overdose.
Ensysce Biosciences stock last closed at $0.42, down 3.88% from the previous day, and has decreased 80.51% in one year. It has underperformed other stocks in the Biotechnology industry by 0.14 percentage points. Ensysce Biosciences stock is currently +83.04% from its 52-week low of $0.23, and -80.95% from its 52-week high of $2.21.
At the moment, there are 19.46M shares of ENSC outstanding. The market capitalization of ENSC is $8.19M. In the last 24 hours, 106,000 ENSC shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy ENSC shares.
We believe that eToro is the best brokerage. eToro gives you:
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen your brokerage, you'll need to fill out some personal information so you can invest in ENSC today.
Now that you have filled out your info on stock market app, you need to deposit funds:
Check out the walkthrough below if you need help depositing money into your brokerage account.
After you have identified the best place to buy Ensysce Biosciences stock, it's very important to evaluate their stock before you invest, so you truly comprehend the risk and opportunity.
WallStreetZen was created to help average investors do more in-depth fundamental analysis.
You can view all of the due diligence checks on ENSC's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge ENSC's true value.
You can access more valuation analysis on ENSC's stock here.
Out of 1 sell side analysts who research ENSC, the consensus analyst rating on ENSC is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are projecting on the Ensysce Biosciences stock forecast page.
In the past year, insiders at ENSC have bought more shares than they have sold.
Bob G. Gower, Director of ENSC, was the latest ENSC insider to buy. They bought $198,000.00 worth of ENSC shares on Aug 7, 2026.
Dig into more about who owns ENSC shares here.
No, Ensysce Biosciences doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
There are two primary types of orders:
Hit the Open button and your broker will place the order.
If you require more help investing in stocks on eToro, click the how to video below:
Now that you own some ENSC stock, you'll want to keep up with your stock purchase.
Create a watchlist to get notified of the latest news about your ENSC stock.
To summarize, here are the 6 steps you need to take to buy Ensysce Biosciences stock right now:
If you require a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to watch your investment in Ensysce Biosciences, create a watchlist on WallStreetZen today.